322 related articles for article (PubMed ID: 24418478)
1. Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes.
IJspeert H; Driessen GJ; Moorhouse MJ; Hartwig NG; Wolska-Kusnierz B; Kalwak K; Pituch-Noworolska A; Kondratenko I; van Montfrans JM; Mejstrikova E; Lankester AC; Langerak AW; van Gent DC; Stubbs AP; van Dongen JJ; van der Burg M
J Allergy Clin Immunol; 2014 Apr; 133(4):1124-33. PubMed ID: 24418478
[TBL] [Abstract][Full Text] [Related]
2. A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency.
Lee YN; Frugoni F; Dobbs K; Walter JE; Giliani S; Gennery AR; Al-Herz W; Haddad E; LeDeist F; Bleesing JH; Henderson LA; Pai SY; Nelson RP; El-Ghoneimy DH; El-Feky RA; Reda SM; Hossny E; Soler-Palacin P; Fuleihan RL; Patel NC; Massaad MJ; Geha RS; Puck JM; Palma P; Cancrini C; Chen K; Vihinen M; Alt FW; Notarangelo LD
J Allergy Clin Immunol; 2014 Apr; 133(4):1099-108. PubMed ID: 24290284
[TBL] [Abstract][Full Text] [Related]
3. Human RAG mutations: biochemistry and clinical implications.
Notarangelo LD; Kim MS; Walter JE; Lee YN
Nat Rev Immunol; 2016 Apr; 16(4):234-46. PubMed ID: 26996199
[TBL] [Abstract][Full Text] [Related]
4. Clinical, immunologic, and genetic characteristics of RAG mutations in 15 Chinese patients with SCID and Omenn syndrome.
Bai X; Liu J; Zhang Z; Liu C; Zhang Y; Tang W; Dai R; Wu J; Tang X; Zhang Y; Ding Y; Jiang L; Zhao X
Immunol Res; 2016 Apr; 64(2):497-507. PubMed ID: 26476733
[TBL] [Abstract][Full Text] [Related]
5. Recombination activity of human recombination-activating gene 2 (RAG2) mutations and correlation with clinical phenotype.
Tirosh I; Yamazaki Y; Frugoni F; Ververs FA; Allenspach EJ; Zhang Y; Burns S; Al-Herz W; Noroski L; Walter JE; Gennery AR; van der Burg M; Notarangelo LD; Lee YN
J Allergy Clin Immunol; 2019 Feb; 143(2):726-735. PubMed ID: 29772310
[TBL] [Abstract][Full Text] [Related]
6. Omenn syndrome does not live by V(D)J recombination alone.
Marrella V; Maina V; Villa A
Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):525-31. PubMed ID: 22001740
[TBL] [Abstract][Full Text] [Related]
7. Human syndromes of immunodeficiency and dysregulation are characterized by distinct defects in T-cell receptor repertoire development.
Yu X; Almeida JR; Darko S; van der Burg M; DeRavin SS; Malech H; Gennery A; Chinn I; Markert ML; Douek DC; Milner JD
J Allergy Clin Immunol; 2014 Apr; 133(4):1109-15. PubMed ID: 24406074
[TBL] [Abstract][Full Text] [Related]
8. The immunophenotypic and immunogenotypic B-cell differentiation arrest in bone marrow of RAG-deficient SCID patients corresponds to residual recombination activities of mutated RAG proteins.
Noordzij JG; de Bruin-Versteeg S; Verkaik NS; Vossen JM; de Groot R; Bernatowska E; Langerak AW; van Gent DC; van Dongen JJ
Blood; 2002 Sep; 100(6):2145-52. PubMed ID: 12200379
[TBL] [Abstract][Full Text] [Related]
9. [Omenn Syndrome and DNA recombination defects].
Yachie A
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(3):179-189. PubMed ID: 28747605
[TBL] [Abstract][Full Text] [Related]
10. Analysis of mutations and recombination activity in RAG-deficient patients.
Asai E; Wada T; Sakakibara Y; Toga A; Toma T; Shimizu T; Nampoothiri S; Imai K; Nonoyama S; Morio T; Muramatsu H; Kamachi Y; Ohara O; Yachie A
Clin Immunol; 2011 Feb; 138(2):172-7. PubMed ID: 21131235
[TBL] [Abstract][Full Text] [Related]
11. Modeling altered T-cell development with induced pluripotent stem cells from patients with RAG1-dependent immune deficiencies.
Brauer PM; Pessach IM; Clarke E; Rowe JH; Ott de Bruin L; Lee YN; Dominguez-Brauer C; Comeau AM; Awong G; Felgentreff K; Zhang YH; Bredemeyer A; Al-Herz W; Du L; Ververs F; Kennedy M; Giliani S; Keller G; Sleckman BP; Schatz DG; Bushman FD; Notarangelo LD; Zúñiga-Pflücker JC
Blood; 2016 Aug; 128(6):783-93. PubMed ID: 27301863
[TBL] [Abstract][Full Text] [Related]
12. V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations.
Villa A; Sobacchi C; Notarangelo LD; Bozzi F; Abinun M; Abrahamsen TG; Arkwright PD; Baniyash M; Brooks EG; Conley ME; Cortes P; Duse M; Fasth A; Filipovich AM; Infante AJ; Jones A; Mazzolari E; Muller SM; Pasic S; Rechavi G; Sacco MG; Santagata S; Schroeder ML; Seger R; Strina D; Ugazio A; Väliaho J; Vihinen M; Vogler LB; Ochs H; Vezzoni P; Friedrich W; Schwarz K
Blood; 2001 Jan; 97(1):81-8. PubMed ID: 11133745
[TBL] [Abstract][Full Text] [Related]
13. More than just SCID--the phenotypic range of combined immunodeficiencies associated with mutations in the recombinase activating genes (RAG) 1 and 2.
Niehues T; Perez-Becker R; Schuetz C
Clin Immunol; 2010 May; 135(2):183-92. PubMed ID: 20172764
[TBL] [Abstract][Full Text] [Related]
14.
Chen R; Lukianova E; van der Loeff IS; Spegarova JS; Willet JDP; James KD; Ryder EJ; Griffin H; IJspeert H; Gajbhiye A; Lamoliatte F; Marin-Rubio JL; Woodbine L; Lemos H; Swan DJ; Pintar V; Sayes K; Ruiz-Morales ER; Eastham S; Dixon D; Prete M; Prigmore E; Jeggo P; Boyes J; Mellor A; Huang L; van der Burg M; Engelhardt KR; Stray-Pedersen A; Erichsen HC; Gennery AR; Trost M; Adams DJ; Anderson G; Lorenc A; Trynka G; Hambleton S
Sci Immunol; 2024 May; 9(95):eade5705. PubMed ID: 38787962
[TBL] [Abstract][Full Text] [Related]
15. Phenotypical heterogeneity in RAG-deficient patients from a highly consanguineous population.
Meshaal SS; El Hawary RE; Abd Elaziz DS; Eldash A; Alkady R; Lotfy S; Mauracher AA; Opitz L; Pachlopnik Schmid J; van der Burg M; Chou J; Galal NM; Boutros JA; Geha R; Elmarsafy AM
Clin Exp Immunol; 2019 Feb; 195(2):202-212. PubMed ID: 30307608
[TBL] [Abstract][Full Text] [Related]
16. Noncore RAG1 regions promote Vβ rearrangements and αβ T cell development by overcoming inherent inefficiency of Vβ recombination signal sequences.
Horowitz JE; Bassing CH
J Immunol; 2014 Feb; 192(4):1609-19. PubMed ID: 24415779
[TBL] [Abstract][Full Text] [Related]
17. N-terminal truncated human RAG1 proteins can direct T-cell receptor but not immunoglobulin gene rearrangements.
Noordzij JG; Verkaik NS; Hartwig NG; de Groot R; van Gent DC; van Dongen JJ
Blood; 2000 Jul; 96(1):203-9. PubMed ID: 10891452
[TBL] [Abstract][Full Text] [Related]
18. A newly found homozygous mutation in recombination activating gene 1 in a patient with leaky severe combined immunodeficiency disorder.
Salari F; Zaremehrjardi F; Arshi S; Bemanian MH; Fallahpour M; Shokri S; Seif F; Movahedi M; Nabavi M
Mol Biol Rep; 2019 Dec; 46(6):6571-6575. PubMed ID: 31520268
[TBL] [Abstract][Full Text] [Related]
19. Three faces of recombination activating gene 1 (RAG1) mutations.
Patiroglu T; Akar HH; Van Der Burg M
Acta Microbiol Immunol Hung; 2015 Dec; 62(4):393-401. PubMed ID: 26689875
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in understanding RAG deficiencies.
Gennery A
F1000Res; 2019; 8():. PubMed ID: 30800289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
